source
- UCSF Receives Major Gift to Advance Research and ModernizationKathy Chiao and Ken Hao commit $100 million for major capital projects, cancer research, and innovation at UCSF — building on a recent $75 million gift to UC Davis for veterinary medicine.onclive · 2mo ago↗ source
- Emerging Clinical Trials and Future Therapeutic Strategies in Recurrent Endometrial CancerThe panel surveys the clinical trial landscape and emerging therapeutic strategies for patients with recurrent endometrial cancer, particularly those who have progressed on frontline checkpoint inh…onclive · 2mo ago↗ source
- CLL-321 Trial Efficacy and Safety Results AnalysisPhase 3 results: pirtobrutinib boosts PFS, delays next treatment after prior BTK therapy, and shows low cardiac toxicity.